Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
Indelicato DJ, Rotondo RL, Krasin MJ, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Morris CG, Bradley JA.
Indelicato DJ, et al.
Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):968-976. doi: 10.1016/j.ijrobp.2019.12.036. Epub 2020 Jan 25.
Int J Radiat Oncol Biol Phys. 2020.
PMID: 31987977
Clinical Trial.